NCT03732560
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Local Institution Parsippany, New Jersey, United States
Clinical trial condition
Melanoma
Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.
1,012 public trials
175 recruiting studies
Melanoma trial results
Completed
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
NCT02643303
- Conditions
- Adenocarcinoma, Bladder Cancer, Breast Cancer, +65 more
- Locations
-
- Research Facility Atlanta, Georgia, United States
- Research Facility Lebanon, New Hampshire, United States
- Research Facility Buffalo, New York, United States
- Research Facility New York, United States
NCT03517488
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
- Locations
-
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
- UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
- University of California San Diego Moores Cancer Center San Diego, California, United States
- University of California San Francisco Medical Center San Francisco, California, United States
Completed
Nonmyeloablative Allogeneic Transplant
NCT01272817
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adenocarcinoma, +91 more
- Locations
-
- Scripps Green Hospital La Jolla, California, United States
NCT03725449
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysplastic Nevus, Dysplastic Nevus Syndrome, +17 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT02115139
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +20 more
- Locations
-
- ICO Badalona Badalona, Spain
- H. Clinic de Barcelona Barcelona, Spain
- Hospital Vall d'Hebron Barcelona, Spain
- H. Insular de Canarias Las Palmas de Gran Canaria, Spain
NCT02659540
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Stanford Cancer Institute Stanford, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
NCT00623831
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +50 more
- Locations
-
- Krankenhaus Nordwest Frankfurt, Germany
NCT00518206
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Peter MacCallum Cancer Institute East Melbourne, Victoria, Australia
- Austin Health (Ludwig Institute Oncology Unit) Heidelberg, Victoria, Australia
NCT00199901
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Sydney Melanoma Unit - Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Newcastle Melanoma Unit - Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia
- Mater Medical Centre, Princess Alexandra Hospital Woolloongabba, Queensland, Australia
- Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia